27,221 Shares in DocuSign, Inc. (NASDAQ:DOCU) Acquired by Meeder Asset Management Inc.

→ The AI stock to buy right now (From StockEarnings) (Ad)

Meeder Asset Management Inc. acquired a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 27,221 shares of the company's stock, valued at approximately $1,618,000.

Other hedge funds have also made changes to their positions in the company. Assenagon Asset Management S.A. increased its stake in shares of DocuSign by 321.3% during the third quarter. Assenagon Asset Management S.A. now owns 214,877 shares of the company's stock valued at $9,025,000 after acquiring an additional 163,875 shares during the period. Executive Wealth Management LLC bought a new stake in DocuSign during the third quarter worth approximately $1,000,000. SG Americas Securities LLC boosted its holdings in DocuSign by 93.1% during the fourth quarter. SG Americas Securities LLC now owns 78,423 shares of the company's stock worth $4,662,000 after buying an additional 37,801 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in DocuSign by 77.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company's stock worth $51,057,000 after buying an additional 531,682 shares in the last quarter. Finally, Grimes & Company Inc. bought a new stake in DocuSign during the third quarter worth approximately $12,047,000. Institutional investors and hedge funds own 77.64% of the company's stock.

DocuSign Trading Up 0.3 %

DOCU traded up $0.19 during trading on Monday, hitting $59.66. The stock had a trading volume of 1,331,118 shares, compared to its average volume of 3,634,304. The firm has a market cap of $12.25 billion, a PE ratio of 165.92, a P/E/G ratio of 5.20 and a beta of 0.89. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76. The company has a 50 day simple moving average of $55.48 and a 200-day simple moving average of $51.10.


DocuSign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, March 7th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.09 by $0.06. The firm had revenue of $712.39 million for the quarter, compared to the consensus estimate of $698.05 million. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. As a group, sell-side analysts anticipate that DocuSign, Inc. will post 0.86 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other DocuSign news, Director Teresa Briggs sold 499 shares of the firm's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $52.99, for a total value of $26,442.01. Following the sale, the director now directly owns 6,169 shares in the company, valued at approximately $326,895.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other DocuSign news, Director Teresa Briggs sold 499 shares of the firm's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $52.99, for a total value of $26,442.01. Following the sale, the director now directly owns 6,169 shares in the company, valued at approximately $326,895.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the sale, the chief executive officer now owns 111,767 shares in the company, valued at $6,847,964.09. The disclosure for this sale can be found here. Insiders have sold 39,871 shares of company stock worth $2,276,199 in the last ninety days. Insiders own 17.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. TheStreet upgraded shares of DocuSign from a "d+" rating to a "c-" rating in a report on Tuesday, December 19th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $50.00 price objective on shares of DocuSign in a research note on Friday, January 12th. Wells Fargo & Company decreased their price objective on shares of DocuSign from $55.00 to $45.00 and set an "underweight" rating for the company in a research note on Monday, February 5th. JMP Securities reaffirmed a "market outperform" rating and issued a $84.00 price objective on shares of DocuSign in a research note on Monday, January 22nd. Finally, Morgan Stanley raised shares of DocuSign from an "underweight" rating to an "equal weight" rating and raised their price objective for the stock from $49.00 to $64.00 in a research note on Tuesday, January 16th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $58.33.

Get Our Latest Stock Report on DocuSign

DocuSign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

→ Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad)

Should you invest $1,000 in DocuSign right now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: